Dhananjay Singh has taken over from Sreenath NS, who is retiring after 36 years of service with Merck in India.
“Dhananjay’s expertise in market dynamics and multi-stakeholder relationship management will further strengthen Merck Life Science’s position in the Indian market,” said Pratima Reddy, country speaker, Merck India.
“Together with the India country leadership team, I look forward to his continued leadership to spearhead initiatives aimed at shaping India’s narrative towards people-centric performance and progress.” added Reddy.
In his role as MD, Dhananjay Singh will be responsible for driving the life science strategy in India, ensuring governance and compliance alongside other leaders from Merck’s businesses in India.
Dhananjay Singh joined SigmaAldrich in 1997. Over the years he took on several leadership roles in Commercial Organisation before his appointment as head of Science & Lab Solutions Commercial for India, a position he held since 2022.
